Article
Different histopathology but the same clonality: ALK rearrangement in a patient with metastatic non-small-cell lung cancer.
International journal of clinical and experimental pathology - 1 Jan 2015
Zhao Jing, Zhou Jianya, Chen Zhen, Wang Bo, Zhang Xiuming, Zhou Jianying, Ding Wei
Abstract excerpt
EML4-ALK rearrangement is detected in 2% to 7% of lung adenocarcinomas, these tumors are sensitive to crizotinib. The histologic feature of ALK translocated non-small-cell lung cancer (NSCLC) has been studied, presence of signet-ring cells was a powerful histologic indicator of ALK rearrangement, and this characteristic histology was present both in primary sites and metastases. However, the case we discribed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
